undamentalytics Newsletter

Aemetis, Inc income statement

In fiscal 2025, Aemetis, Inc reported revenue of $198m, down 26.2% on the year before, operating income of −$37.2m (a -18.8% margin) and net income of −$77.0m, or −$1.28 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Aemetis, Inc: income statement, annual
Fiscal year2010Dec 20102011Dec 20112012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue8142189178208147143150172202166212257187268198220
Cost of revenue8137198159171142132147166189155204262185268209206
Gross profit−05−918374123513118−62−1−124
Research and development01110002000000———
Selling, general and administrative59121513121213161717242939403635
Operating income−5−5−21224−9−1−12−11−5−6−16−34−37−40−37−12
Interest expense414181210101719262123242940475355
Income before tax−9−18−5−247−27−16−32−3600−47−107−100−98−96−72
Income tax0−0−10000001−1−01−54−11−19−12
Net income−9−18−4−247−27−16−32−36−39−37−47−108−46−88−77−60
Diluted EPS−$0.10−$0.18−$0.28−$1.28$0.34−$1.37−$0.79−$1.53−$1.63−$1.75−$1.74−$1.54−$3.12−$1.22−$1.91−$1.28−$0.90
Diluted shares (average)87m104m——21m20m20m20m20m20m21m31m35m38m46m60m67m
EBITDA−4−3−18729−44−8−6−1−1−10−29−30−32−28−2

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: AMTX vs GEVOAMTX vs FTKAMTX vs NLAMTX vs LXFR

More: Specialty Chemicals stocks compared, Materials sector, rankings of US companies

Figures from Aemetis, Inc's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Aemetis, Inc.